532 A cross-cohort examination of factors impacting immunotherapy survival in non-small cell lung cancer (NSCLC)

• Chris Ward,
• Nikita Kotlov,
• Krystle Nomie,
• Konstantin Danilov,
• Dhruv Bansal,
• Ivan Valiev,
• Vladimir Kushnarev,
• Ammar Al-Obaidi,
• Timothy Pluard,
• Artem Tarasov,
• Anastasiia Makarova,
• Anna Butusova,
• Anna Love,
• Janakiraman Subramanian,
• Alexander Bagaev

Affiliations

Chris Ward

2Saint Luke’s Cancer Institute, Kansas City, MO, USA

Nikita Kotlov

1BostonGene, Corp., Waltham, MA, USA

Krystle Nomie

1BostonGene, Corp., Waltham, MA, USA

Konstantin Danilov

1BostonGene, Corp., Waltham, MA, USA

Dhruv Bansal

2Saint Luke’s Cancer Institute, Kansas City, MO, USA

Ivan Valiev

1BostonGene, Corp., Waltham, MA, USA

Vladimir Kushnarev

1BostonGene, Corp., Waltham, MA, USA

Ammar Al-Obaidi

3University of Missouri Kansas City, Kansas City, MO, USA

Timothy Pluard

2Saint Luke’s Cancer Institute, Kansas City, MO, USA

Artem Tarasov

1BostonGene, Corp., Waltham, MA, USA

Anastasiia Makarova

1BostonGene, Corp., Waltham, MA, USA

Anna Butusova

1BostonGene, Corp., Waltham, MA, USA

Anna Love

1BostonGene, Corp., Waltham, MA, USA

Janakiraman Subramanian

4Inova Schar Cancer Institute, Fairfax, VA, USA

Alexander Bagaev

1BostonGene, Corp., Waltham, MA, USA